Generation of an HBV core phenotyping assay for evaluating HBV capsid compounds
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Journal of Virological Methods
- Vol. 292, 114117
Abstract
No abstract availableKeywords
Funding Information
- Gilead Sciences Inc
This publication has 20 references indexed in Scilit:
- High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core proteinProceedings of the National Academy of Sciences, 2015
- Core protein: A pleiotropic keystone in the HBV lifecycleAntiviral Research, 2015
- Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis BGastroenterology, 2014
- Identification of Disubstituted Sulfonamide Compounds as Specific Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA FormationAntimicrobial Agents and Chemotherapy, 2012
- HBV DNA replication mediated by cloned patient HBV reverse transcriptase genes from HBV genotypes A–H and its use in antiviral phenotyping assaysJournal of Virological Methods, 2011
- A Mutant Hepatitis B Virus Core Protein Mimics Inhibitors of Icosahedral Capsid Self-AssemblyBiochemistry, 2009
- Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis BNew England Journal of Medicine, 2008
- In vitro antiviral susceptibility of full-length clinical hepatitis B virus isolates cloned with a novel expression vectorAntiviral Research, 2004
- Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of NucleocapsidsScience, 2003
- The Crystal Structure of the Human Hepatitis B Virus CapsidMolecular Cell, 1999